A review and meta-analysis of data from 28 countries found significant increases in resistance to clarithromycin, ...

Further tests found seasonal flu, rhinovirus, COVID, and other common respiratory viruses, alongside malaria and ...

pylori and its mutations in dyspeptic patients from rural areas of India, with minimal or no access to diagnostic laboratories. Infections with H. pylori affect over 43 per cent of the world’s ...

INR:8322. delhi king satte ki khabar Flumatinib, the first second-generation Bcr-Abl tyrosine kinase inhibitor in China, is launched on the market Two ...

CRISPR-based test FELUDA detects H. pylori, the bacteria linked to ulcers and gastric cancer, advancing diagnostic precision.

INR:1310. app 22bet android Helicobacter pylori infection is no longer a scary thing. RedHill's new drug Talicia comes to help Comparison of performance in the ...

Eliminating the potential risk of gastric cancer, FDA approves innovative Helicobacter pylori elimination therapy Iron carrier-coupled antibiotics are expected to be launched on the market Guizhou Bai ...

In a significant advancement for global healthcare, researchers have developed a CRISPR-based diagnostic tool, FELUDA, to ...

A team of Indian scientists, including from CSIR-Institute of Genomics and Integrative Biology (IGIB) and AIIMS has developed ...

In its report, the Committee on Public Undertakings recommended that the controlling ministry and Dept of Public Enterprises should anticipate future vacancies & take required actions.

IGIB and AIIMS develop a CRISPR-based FELUDA test for detecting H. pylori using en31-FnCas9 tech, aiding rural diagnostics.

New Delhi: Researchers have developed a new method for detecting H. pylori and its mutations in dyspeptic patients, which ...